GlassScriptPhysician profile
Ryan M Flanigan
NPI 1659497584
$156,402.68
in general payments reported to CMS, 2019-2025
8 companies · $5,049 in 2025
The $5,049 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $4,677 · 2021: $2,274 · 2022: $14K · 2023: $117K · 2024: $2,457 · 2025: $5,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $95K · Travel and Lodging: $26K · Food and Beverage: $4,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $94,546.87 |
| Travel and Lodging | $25,610.52 |
| Food and Beverage | $4,519.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $149,808.35 | 2019-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $4,335.33 | 2020-2025 | |
| Arthrex, INC. | $1,922.15 | 2020-2025 | |
| Stryker Corporation | $139.86 | 2020-2021 | |
| Organogenesis INC. | $84.45 | 2024 | Nushield |
| Innovation Technologies INC | $63.52 | 2021-2022 | |
| Smith+Nephew, INC. | $34.52 | 2021 | |
| Bioventus LLC | $14.50 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Flanigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.